Showing results (1-10 of 144) with videos related to
Sort By:
Pageof 15
British Journal of Clinical Pharmacology|March 1, 1993
The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population studyE Skjelbo, L F Gram, K BrøsenClinical Pharmacology and Therapeutics|January 1, 1991
The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramineE Skjelbo, K Brøsen, J Hallas, et al.Clinical Pharmacology and Therapeutics|March 1, 1996
Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in TanzaniansE Skjelbo, T K Mutabingwa, I b Bygbjerg, et al.British Journal of Clinical Pharmacology|June 1, 1991
The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel studyS A Ward, N A Helsby, E Skjelbo, et al.British Journal of Clinical Pharmacology|September 1, 1992
Inhibitors of imipramine metabolism by human liver microsomesE Skjelbo, K BrøsenClinical Pharmacology and Therapeutics|March 1, 1992
The relationship between paroxetine and the sparteine oxidation polymorphismS H Sindrup, K Brøsen, L F Gram, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1988
Imipramine: a model substance in pharmacokinetic researchL F GramL'Encephale|January 1, 1982
The contribution of pharmacokinetics to the best use of benzodiazepines and antidepressantsL F GramClinical Neuropharmacology|January 1, 1990
Inadequate dosing and pharmacokinetic variability as confounding factors in assessment of efficacy of antidepressantsL F GramPageof 15